Target intelligence / Profile preview

Common gamma-chain cytokine receptor subunit (γc (also known as CD132 or IL-2Rγ))

Target
γc (also known as CD132 or IL-2Rγ)
Molecular classification
Receptor, Cytokine receptor subunit, Type I cytokine receptor family member
01

Overview

The common gamma-chain cytokine receptor subunit is a shared component of several key interleukin receptors—specifically those for interleukin 2 (IL‑2), IL‑4, IL‑7, IL‑9, IL‑15, and IL‑21. Also known as CD132 or IL–2Rγ, it forms part of heterodimeric or heterotrimeric complexes with other “private” alpha/beta chains unique to each cytokine’s receptor system. The γc subunit is essential for signal transduction via these receptors; upon ligand binding it recruits Janus kinases (primarily JAK3), leading to activation of STAT transcription factors that drive gene expression programs critical for lymphocyte development, differentiation, survival, and function across all major branches of the adaptive immune system. Deficiency or dysfunction results in profound immunodeficiency syndromes such as X-linked SCID due to failure of T-cell and NK-cell development.

Other names
Common gamma chainγcCD132Interleukin 2 receptor subunit gammaIL-2Rγ
02

Mechanism of action

Drugs that target this pathway typically act by blocking the interaction between specific interleukins (e.g., IL‑2, IL‑4) and their receptors containing the common gamma-chain, thereby inhibiting downstream JAK/STAT signaling pathways involved in immune cell activation and proliferation.

03

Biological functions

Signal transductionImmune responseLymphocyte development and homeostasisCell proliferation and survival of immune cells
04

Disease associations

Immunodeficiency (notably X-linked severe combined immunodeficiency, SCID)Cancer (due to its role in lymphocyte regulation)Inflammation
05

Safety considerations

Therapeutic modulation of this pathway can lead to broad immunosuppression or immune dysregulation due to its central role in multiple cytokine signaling pathways.This raises risks for infections and impaired immune surveillance.
06

Biomarkers

Mutations in the gene encoding the common gamma-chain (IL2RG) serve as biomarkers for X-linked SCID.Expression levels of γc may also be used to monitor certain immunodeficiencies.

Beyond the preview

Go deeper on Common gamma-chain cytokine receptor subunit (γc (also known as CD132 or IL-2Rγ)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Common gamma-chain cytokine receptor subunit (γc (also known as CD132 or IL-2Rγ)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call